Virtu Financial’s Precision BioSciences DTIL Stock Holding History

Virtu Financial’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,166	Closed	-$84K	–	1794
2025 Q3	$84K	Buy	+15,166	New	+$72.6K	﹤0.01%	1067
2023 Q4	–	Sell	-911	Closed	-$9K	–	1669
2023 Q3	$9K	Buy	+911	New	+$14K	﹤0.01%	1114
2022 Q4	–	Sell	-886	Closed	-$35K	–	1741
2022 Q3	$35K	Buy	+886	New	+$42.1K	﹤0.01%	1280
2021 Q1	–	Sell	-646	Closed	-$162K	–	1693
2020 Q4	$162K	Buy	+646	New	+$158K	0.02%	927

Other funds holding DTIL

EAM

Empery Asset Management New York $83M AUM

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Virtu Financial's DTIL Position: Q4 2025 in Review

Virtu Financial sold out of Precision BioSciences (DTIL) in Q4 2025, closing a stake of 15,166 shares — an estimated $84K sold.

Virtu Financial first reported a position in DTIL in Q4 2020 and held it in 4 quarters. The position peaked at $162K in Q4 2020. 69 funds tracked by Wall St. Rank hold DTIL as of Q4 2025.

Virtu Financial reported no remaining Precision BioSciences position as of Q4 2025 after selling out during the quarter.
Virtu Financial sold 15,166 Precision BioSciences shares in Q4 2025, an estimated $84K.
Virtu Financial first reported a position in Precision BioSciences in Q4 2020 and held it in 4 quarters.
Virtu Financial's Precision BioSciences position peaked at $162K in Q4 2020.
69 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.